Intelligent Bio Solutions (INBS) Prices $4M Underwritten Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
October 2, 2023 8:32 AM EDTNEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the Company), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the pricing of an underwritten public offering of units (the Units) for gross proceeds of approximately $4.0 million.
Ladenburg Thalmann & Co. Inc. is acting as the sole bookrunning manager for the offering.
The underwritten public offering consists of 7,272,727 shares of common stock, par value $0.01 per share, of the Company (the Common Stock) (or shares of the Companys Series E Convertible Preferred Stock (the... More



